Your browser doesn't support javascript.
Association between COVID-19 morbidity, mortality, and gross domestic product, overweight/ obesity, non-communicable diseases, vaccination rate: A cross-sectional study.
Oshakbayev, Kuat; Zhankalova, Zulfiya; Gazaliyeva, Meruyert; Mustafin, Khalit; Bedelbayeva, Gulnara; Dukenbayeva, Bibazhar; Otarbayev, Nurzhan; Tordai, Attila.
  • Oshakbayev K; National Research Oncology Center, Metabolic Syndrome Department, Street Kerey Zhanibek Khans, 3, Nur-Sultan (Astana) 010000, Kazakhstan; ANADETO Medical Center, Street Kerey Zhanibek khans, 22, Nur-Sultan (Astana) 010000, Kazakhstan. Electronic address: okp.kuat@gmail.com.
  • Zhankalova Z; Asfendiyarov Kazakh National Medical University, Faculty of Postgraduate Education, Department of General Medical Practice, #1 Street Tole Bi, 94, Almaty 050000, Kazakhstan. Electronic address: zulfiya-zhankalo@mail.ru.
  • Gazaliyeva M; Medical University Karaganda, Faculty of Internal Medicine, Street Gogol, 40, Karaganda 100000, Kazakhstan. Electronic address: gazaliyeva@yandex.ru.
  • Mustafin K; National Center of neurosurgery, Department Surgery, Turan Ave 34/1, Astana, Kazakhstan. Electronic address: halit.mustafin@yandex.ru.
  • Bedelbayeva G; Asfendiyarov Kazakh National Medical University, Faculty of Postgraduate Education, Department of General Medical Practice, #1 Street Tole Bi, 94, Almaty 050000, Kazakhstan. Electronic address: bedelbaeva@mail.ru.
  • Dukenbayeva B; Medical University Astana, Faculty of Pathology and Forensic Medicine, Beybitshilik street 49A, Nur-Sultan (Astana) 010000, Kazakhstan; ANADETO Medical Center, Street Kerey Zhanibek khans, 22, Nur-Sultan (Astana) 010000, Kazakhstan. Electronic address: dukenbaeva74@gmail.com.
  • Otarbayev N; LLP 'Medicare', Member of the Supervisory Board, LLP 'Meirim', Medical Consultant, Nur-Sultan (Astana), Kazakhstan. Electronic address: otarbaev@rambler.ru.
  • Tordai A; Semmelweis University, Dept. Pathophysiology, H-1088 Budapest, Vas u. 17, Hungary. Electronic address: tordai.attila@med.semmelweis-univ.hu.
J Infect Public Health ; 15(2): 255-260, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1693254
ABSTRACT

BACKGROUND:

The spread of COVID-19 depends on a lot of social and economic factors. THE

AIM:

to study the influence of country's gross domestic product, population prevalence of overweight/ obesity, NCD mortality, and vaccination on COVID-19 morbidity and mortality rates.

METHODS:

A cross-sectional study with two phases correlation-regression interrelations in 1) all world countries; 2) all world non-island countries. The study includes the following data from 218 world countries COVID-19 morbidity/mortality rates, GDP per capita, the prevalence of overweight/ obesity, NCD mortality among adults (both sexes), people fully vaccinated against COVID-19.

RESULTS:

An average percentage of the prevalence of overweight among adults in world countries by 2019 was 47.31 ± 15.99%, obesity 18.34 ± 9.64%, while the prevalence by 2016 were 39% and 13%, respectively. Overweight and obesity among adults during three years grew by 21.2% and 40.8%, respectively. Data from the world countries provide significant correlations (p < 0.0001) between COVID-19 morbidity, and GDP (r = 0.517), overweight (r = 0.54), obesity (r = 0.528), NCD mortality (r = 0.537); COVID-19 mortality, and GDP (r = 0.344), overweight (r = 0.514), obesity (r = 0.489), NCD mortality (r = 0.611); GDP, and overweight (r = 0.507), obesity (r = 0.523), NCD mortality (r = 0.35), fully vaccinated people (r = 0.754). An increase in fully vaccinated people, from 3% to 30% of world population, decreases new confirmed COVID-19 cases, although the dependence was not significant (p = 0.07). Data from non-island world countries provides more highly significant correlations (p < 0.0001) between COVID-19 morbidity, and GDP (r = 0.616), overweight (r = 0.581), obesity (r = 0.583); COVID-19 mortality, and GDP (r = 0.43), overweight (r = 0.556), obesity (r = 0.539); GDP, and overweight (r = 0.601), obesity (r = 0.633). The differences of correlation coefficients between data of 176 world countries and data of 143 world non-island countries were not significant (Z-scores<1.29; p > 0.05).

CONCLUSION:

The study provides evidence of a significant impact of overweight/obesity prevalence on the increase in COVID-19 morbidity/mortality. Countries with higher GDP have a high overweight/obesity prevalence and possibility to get vaccinated.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Noncommunicable Diseases / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Female / Humans / Male Language: English Journal: J Infect Public Health Journal subject: Communicable Diseases / Public Health Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Noncommunicable Diseases / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Female / Humans / Male Language: English Journal: J Infect Public Health Journal subject: Communicable Diseases / Public Health Year: 2022 Document Type: Article